Cargando…

Epigenetic Markers for Molecular Detection of Prostate Cancer

Prostate cancer is a highly prevalent malignancy, which is clinically silent but curable while organ-confined. Because available screening methods show poor sensitivity and specificity, the development of new molecular markers is warranted. Epigenetic alterations, mainly promoter hypermethylation of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Costa, Vera L., Henrique, Rui, Jerónimo, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2007
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850633/ https://www.ncbi.nlm.nih.gov/pubmed/17325424 http://dx.doi.org/10.1155/2007/356742

Ejemplares similares

Epigenetic regulation of MDR1 gene through post-translational histone modifications in prostate cancer
por: Henrique, Rui, et al.
Publicado: (2013)

Epigenetic modulators as therapeutic targets in prostate cancer
por: Graça, Inês, et al.
Publicado: (2016)

Promise and Challenge: Markers of Prostate Cancer Detection, Diagnosis and Prognosis
por: Troyer, D. A., et al.
Publicado: (2004)

Epigenetic Markers and Response to Chemotherapy in Cancer
por: Strathdee, Gordon
Publicado: (2007)

Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
por: Miranda-Gonçalves, Vera, et al.
Publicado: (2018)

Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential
por: Almeida, Mafalda, et al.
Publicado: (2014)

Corrigendum: Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
por: Miranda-Gonçalves, Vera, et al.
Publicado: (2019)

The Critical Role of Hypoxic Microenvironment and Epigenetic Deregulation in Esophageal Cancer Radioresistance
por: Macedo-Silva, Catarina, et al.
Publicado: (2019)

Large Scale Genomic Instability as an Additive Prognostic Marker in Early Prostate Cancer
por: Pretorius, Maria E., et al.
Publicado: (2009)

Molecular Markers for Early Detection of Cervical Neoplasia
por: Unger, Elizabeth R., et al.
Publicado: (2004)

Loss of Imprinting of IGF2 as an Epigenetic Marker for the Risk of Human Cancer
por: Cui, Hengmi
Publicado: (2007)

The Complex Interplay between Metabolic Reprogramming and Epigenetic Alterations in Renal Cell Carcinoma
por: Lameirinhas, Ana, et al.
Publicado: (2019)

Novel Insights on the Role of Epigenetics in Androgen Receptor’s Expression in Prostate Cancer
por: Camilo, Vânia, et al.
Publicado: (2023)

Integrative epigenetic taxonomy of primary prostate cancer
por: Stelloo, Suzan, et al.
Publicado: (2018)

Epigenetic mechanisms underlying prostate cancer radioresistance
por: Macedo-Silva, Catarina, et al.
Publicado: (2021)

Epigenetic Mechanisms Influencing Epithelial to Mesenchymal Transition in Bladder Cancer
por: Monteiro-Reis, Sara, et al.
Publicado: (2019)

Epigenetic Alterations in Oesophageal Cancer: Expression and Role of the Involved Enzymes
por: Lopes, Nair, et al.
Publicado: (2020)

Targeting the Immune system and Epigenetic Landscape of Urological Tumors
por: Lobo, João, et al.
Publicado: (2020)

Shifting the Cancer Screening Paradigm: The Rising Potential of Blood-Based Multi-Cancer Early Detection Tests
por: Brito-Rocha, Tiago, et al.
Publicado: (2023)

From Therapy Resistance to Targeted Therapies in Prostate Cancer
por: Moreira-Silva, Filipa, et al.
Publicado: (2022)

The Epigenetics of Renal Cell Tumors: from Biology to Biomarkers
por: Henrique, Rui, et al.
Publicado: (2012)

ANX7 as a Bio-Marker in Prostate and Breast Cancer Progression
por: Srivastava, Meera, et al.
Publicado: (2001)

Circulating MicroRNAs as Biomarkers for Prostate Cancer Detection and Metastasis Development Prediction
por: Bidarra, David, et al.
Publicado: (2019)

Use of Markers for the Detection and Treatment of Lung Cancer
por: Vourlekis, Jason S., et al.
Publicado: (2004)

DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types
por: Constâncio, Vera, et al.
Publicado: (2020)

Decoding the usefulness of non-coding RNAs as breast cancer markers
por: Amorim, Maria, et al.
Publicado: (2016)

Overexpression of the Mitotic Checkpoint Genes BUB1 and BUBR1 is Associated with Genomic Complexity in Clear Cell Kidney Carcinomas
por: Pinto, Mafalda, et al.
Publicado: (2008)

Epigenetic modulation and prostate cancer: Paving the way for NK cell anti-tumor immunity
por: dos Reis, Filipa D., et al.
Publicado: (2023)

Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy
por: Lodewijk, Iris, et al.
Publicado: (2021)

Analysis of Epigenetic Alterations in Homologous Recombination DNA Repair Genes in Male Breast Cancer
por: André, Saudade, et al.
Publicado: (2020)

Human Germ Cell Tumors are Developmental Cancers: Impact of Epigenetics on Pathobiology and Clinic
por: Lobo, João, et al.
Publicado: (2019)

Repurposing Old Drugs into New Epigenetic Inhibitors: Promising Candidates for Cancer Treatment?
por: Moreira-Silva, Filipa, et al.
Publicado: (2020)

Serum Protein Expression Profiling for Cancer Detection: Validation of a SELDI-Based Approach for Prostate Cancer
por: Grizzle, William E., et al.
Publicado: (2004)

Diagnostic and Prognostic Molecular Markers in Hepatocellular Carcinoma
por: Mínguez, Beatriz, et al.
Publicado: (2011)

Epigenetic regulation of TP53 is involved in prostate cancer radioresistance and DNA damage response signaling
por: Macedo-Silva, Catarina, et al.
Publicado: (2023)

A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting TMEM97
por: Ramalho-Carvalho, João, et al.
Publicado: (2018)

Anti-neoplastic properties of hydralazine in prostate cancer
por: Graça, Inês, et al.
Publicado: (2014)

Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients
por: Moreira-Barbosa, Catarina, et al.
Publicado: (2018)

The Future of Medical Imaging in the Detection of Early Markers of Disease
por: Croft, Barbara Y.
Publicado: (2004)

Identification of Novel Epigenetic Markers of Prostate Cancer by NotI-Microarray Analysis
por: Dmitriev, Alexey A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8129jkgofk1crfca0kvn8fg9bd